loader image

Coly-Monas 4.5

Therapeutic Category:

Description

Colistimethate Sodium for Injection is a last-resort, intravenous polymyxin antibiotic used to treat life-threatening multidrug-resistant Gram-negative infections, including those caused by Pseudomonas aeruginosa, Acinetobacter baumannii, and Klebsiella pneumoniae. It is crucial in critical care settings when conventional antibiotics fail

Additional information

Dosage

4.5 MIU

Pack Size

1*1

Form

Injection

Manufacturer

Glenmark

Storage Conditions

Ambient Temperature

Shelf Life

2 Years

Delivery Process

Product information is meant for


Wholesalers Distributors Patients Hospitals Pharmacies Government Tenders Importers CROs Clinics Doctors Generic Drugs Branded Drugs Institutional Buyers Comparator Sourcing Product Registration

Disclaimer

  • We do not offer medical advice. Please consult a registered medical practitioner before purchasing.
  • All content and product information on this website is for informational purposes only.
  • Buyers are solely responsible for ensuring patent compliance in their respective countries.
  • Trademarks are used under the provisions of the Trade Marks Act, 1999, Sections 30 and 30(1), permitting fair use.
  • All products are sold in accordance with the Drugs and Cosmetics Act, 1940, as passed by the Parliament of India.

Disclaimer

Trade Marks displayed in compliance with provisions of: provisions Trademark Act, 1999 u/s 30 and 30 (1) of “Fair use”

GNH India is WHO GDP and ISO 9001 2015 Certified Pharmaceutical Wholesaler/ Supplier/ Exporters/ Importer from India of PANTIN-D CAP – Domperidone+ Pantoprazole which is also known as PANTIN and Manufactured by Hetro pharmaceutical. It is available in strength of (30mg) + (40mg) per ml.

PANTIN-D CAP – Domperidone+ Pantoprazole is supplied for Tenders/ Emergency imports/ Un – licensed, Specials, Orphan drug/ Name patient line/ RLD supplies/ Reference listed drugs/ Comparator Drug/ Bio-Similar/ Innovator samples For Clinical trials.

Read more from reference website

Add to quote

DISCLAIMER